Hanmi Faces Another Licensee U-Turn, This Time Janssen On Obesity/Diabetes Drug

 
• By Jung Won Shin
  
Desperate businessmen
Janssen Drops Hanmi's GLP-1/GCG peptide As Glycemic Control Targets Unmet
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from South Korea

More from Focus On Asia